ICU Medical (NASDAQ:ICUI) Research Coverage Started at KeyCorp

KeyCorp assumed coverage on shares of ICU Medical (NASDAQ:ICUIFree Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage issued an overweight rating and a $134.00 target price on the medical instruments supplier’s stock.

Several other analysts have also recently issued reports on the company. TheStreet cut ICU Medical from a c- rating to a d+ rating in a research report on Tuesday, October 10th. CL King started coverage on ICU Medical in a research report on Thursday, December 14th. They set a buy rating and a $110.00 target price on the stock. One investment analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average price target of $122.00.

Read Our Latest Research Report on ICUI

ICU Medical Trading Up 1.7 %

ICUI opened at $101.16 on Tuesday. The stock has a market cap of $2.44 billion, a price-to-earnings ratio of -86.46 and a beta of 0.65. The stock’s 50 day moving average price is $95.14 and its 200-day moving average price is $111.93. ICU Medical has a one year low of $78.28 and a one year high of $212.43. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.99 and a current ratio of 2.63.

Insider Activity

In other news, VP Daniel Woolson sold 1,729 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $88.03, for a total transaction of $152,203.87. Following the completion of the sale, the vice president now owns 9,877 shares in the company, valued at approximately $869,472.31. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 7.50% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Covestor Ltd grew its position in shares of ICU Medical by 86.4% during the 1st quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 57 shares during the period. Captrust Financial Advisors grew its position in shares of ICU Medical by 4.5% during the 2nd quarter. Captrust Financial Advisors now owns 1,327 shares of the medical instruments supplier’s stock valued at $218,000 after acquiring an additional 57 shares during the period. Osaic Holdings Inc. grew its position in shares of ICU Medical by 8.9% during the 2nd quarter. Osaic Holdings Inc. now owns 1,012 shares of the medical instruments supplier’s stock valued at $180,000 after acquiring an additional 83 shares during the period. First Republic Investment Management Inc. grew its position in shares of ICU Medical by 7.6% during the 1st quarter. First Republic Investment Management Inc. now owns 1,438 shares of the medical instruments supplier’s stock valued at $237,000 after acquiring an additional 102 shares during the period. Finally, Wells Fargo & Company MN grew its position in shares of ICU Medical by 4.1% during the 2nd quarter. Wells Fargo & Company MN now owns 2,722 shares of the medical instruments supplier’s stock valued at $485,000 after acquiring an additional 106 shares during the period. Hedge funds and other institutional investors own 91.49% of the company’s stock.

ICU Medical Company Profile

(Get Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters.

Read More

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.